| Name | Sam's Pharmacy 10-6242 |
|---|---|
| Organization Name | Sams East Inc |
| Location | 5870 Sawmill Rd, Dublin, Ohio 43017 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (614) 760-9222 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The field of vaccine development is getting a boost from new research that has identified a promising vaccine delivery approach, which in animal studies produced long-term immune protection after just one immunization.
Genzyme, a Sanofi company, announced today that Health Canada has approved Lemtrada (alemtuzumab) for the management of adult patients with relapsing remitting multiple sclerosis, with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies.
YM BioSciences Inc. a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, today reported operational and financial results for its fiscal year end, ended June 30, 2009.
A new study posted to the bioRxiv* server attempted to explore anti-spike IgG responses, Fc-gamma receptor (FcγR) activation, IgG targeting of immunodominant regions, and recall responses due to seasonal hCoV infections in non-hospitalized COVID-19 patients.
Researchers at the Johns Hopkins Bloomberg School of Public Health have identified a gene in the Anopheles gambiae mosquito's DNA that is central to the insect's ability to defend against infectious pathogens, including Plasmodium, the parasite that causes malaria in humans.
› Verified 2 days ago
| NPI Number | 1568489763 |
| Organization Name | SAMS EAST INC |
| Doing Business As | SAMS PHARMACY 10-6242 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 5870 Sawmill Rd, Dublin, OH 43017 |
| Phone Number | 614-760-9222 |
News Archive
The field of vaccine development is getting a boost from new research that has identified a promising vaccine delivery approach, which in animal studies produced long-term immune protection after just one immunization.
Genzyme, a Sanofi company, announced today that Health Canada has approved Lemtrada (alemtuzumab) for the management of adult patients with relapsing remitting multiple sclerosis, with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies.
YM BioSciences Inc. a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, today reported operational and financial results for its fiscal year end, ended June 30, 2009.
A new study posted to the bioRxiv* server attempted to explore anti-spike IgG responses, Fc-gamma receptor (FcγR) activation, IgG targeting of immunodominant regions, and recall responses due to seasonal hCoV infections in non-hospitalized COVID-19 patients.
Researchers at the Johns Hopkins Bloomberg School of Public Health have identified a gene in the Anopheles gambiae mosquito's DNA that is central to the insect's ability to defend against infectious pathogens, including Plasmodium, the parasite that causes malaria in humans.
› Verified 2 days ago
News Archive
The field of vaccine development is getting a boost from new research that has identified a promising vaccine delivery approach, which in animal studies produced long-term immune protection after just one immunization.
Genzyme, a Sanofi company, announced today that Health Canada has approved Lemtrada (alemtuzumab) for the management of adult patients with relapsing remitting multiple sclerosis, with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies.
YM BioSciences Inc. a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, today reported operational and financial results for its fiscal year end, ended June 30, 2009.
A new study posted to the bioRxiv* server attempted to explore anti-spike IgG responses, Fc-gamma receptor (FcγR) activation, IgG targeting of immunodominant regions, and recall responses due to seasonal hCoV infections in non-hospitalized COVID-19 patients.
Researchers at the Johns Hopkins Bloomberg School of Public Health have identified a gene in the Anopheles gambiae mosquito's DNA that is central to the insect's ability to defend against infectious pathogens, including Plasmodium, the parasite that causes malaria in humans.
› Verified 2 days ago
Bioscrip Pharmacy Services Type: Medicare Supplier Location: 5700 Perimeter Dr, Dublin, Ohio 43017 Phone: (614) 850-6700 | |
Cvs Pharmacy #06161 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7470 Sawmill Rd, Dublin, Ohio 43016 Phone: (614) 889-8662 | |
Cvs Pharmacy #06150 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 305 W Bridge St, Dublin, Ohio 43017 Phone: (614) 889-6530 | |
Cvs Pharmacy #16193 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 6000 Sawmill Rd, Dublin, Ohio 43017 Phone: (614) 798-8172 | |
Walgreens #6115 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 6805 Hospital Dr, Dublin, Ohio 43016 Phone: (614) 336-0431 |